160 478

Cited 0 times in

Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus.

Jun, HS; Kang, Y; Notkins, AL; Yoon, JW
Journal of virology, 71(12):9782-9785, 1997
Journal Title
Journal of virology
Molecular pathogenic mechanisms for virus-induced disease have received considerable attention. Encephalomyocarditis (EMC) virus-induced diabetes in mice has been extensively studied to elucidate the cellular and molecular mechanisms involved in the development of this disease. In this study, we report for the first time that a single point mutation at nucleotide position 3155 or 3156 of the recombinant EMC viral genome, located on the major capsid protein VP1, which causes an amino acid change, results in the gain or loss of viral diabetogenicity. A G base at nucleotide position 3155 (alanine at amino acid position 776 of the EMC virus polyprotein [Ala776]; GCC) results in viral diabetogenicity, whereas the substitution of other bases at the same or next position results in a loss of viral diabetogenicity. This finding provides clear evidence that a point mutation at a critical site in a viral genome affects the ability of the virus to cause a cell-specific disease.
MeSH terms
Alanine/*geneticsAnimalsAntibodies, Viral/bloodBlood Glucose/analysisCardiovirus Infections/immunology/metabolism/*virologyDiabetes Mellitus, Type 1/*virologyEncephalomyocarditis virus/*genetics/immunology/metabolismInsulin/metabolismMicePancreas/metabolism/pathology*Point MutationRecombination, GeneticThreonine/*genetics
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Journal Papers > School of Medicine / Graduate School of Medicine > Endocrinology & Metabolism
AJOU Authors
강, 엽윤, 지원
Full Text Link
Files in This Item:
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.